Heska Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSKA research report →
Companywww.heska.com
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops.
- CEO
- Kevin S. Wilson
- IPO
- 1997
- Employees
- 808
- HQ
- Loveland, CO, US
Price Chart
Valuation
- Market Cap
- $1.31B
- P/E
- -67.36
- P/S
- 5.09
- P/B
- 2.94
- EV/EBITDA
- -61.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.20%
- Op Margin
- -7.89%
- Net Margin
- -7.16%
- ROE
- -4.29%
- ROIC
- -3.12%
Growth & Income
- Revenue
- $257.31M · 1.41%
- Net Income
- $-18,424,000 · -14057.58%
- EPS
- $-1.78 · -13584.85%
- Op Income
- $-20,298,000
- FCF YoY
- -634.20%
Performance & Tape
- 52W High
- $120.03
- 52W Low
- $57.83
- 50D MA
- $117.59
- 200D MA
- $87.26
- Beta
- 1.60
- Avg Volume
- 336.67K
Get TickerSpark's AI analysis on HSKA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 13, 23 | Davis Stephen L | sell | 500 |
| Jun 13, 23 | Hasenmaier Joachim A. | sell | 2,004 |
| Jun 13, 23 | Eyl Steven M. | other | 4,056 |
| Jun 13, 23 | Eyl Steven M. | other | 33,111 |
| Feb 28, 22 | Eyl Steven M. | other | 20,000 |
| Jun 13, 23 | Eyl Steven M. | sell | 1,146 |
| Jun 13, 23 | Eyl Steven M. | sell | 3,041 |
| Jun 13, 23 | Eyl Steven M. | sell | 1,918 |
| Jun 13, 23 | Eyl Steven M. | sell | 1,372 |
| Jun 13, 23 | Eyl Steven M. | sell | 7,691 |
Our HSKA Coverage
We haven't published any research on HSKA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HSKA Report →